NAD+
500 mgCoenzyme supplied as a 500 mg research presentation. Full technical information, research detail and documentation for this compound are pending verification.
- Product
- NAD+
- Product Type
- Coenzyme
- Presentation
- 500 mg
- Strength
- 500 mg
- Research Class
- Mitochondrial Research
- Status
- Regulatory Status To Be Confirmed
Technical Specifications
| Presentation | 500 mg |
|---|---|
| Product Type | Coenzyme |
Research & Regulatory Status
Regulatory status is jurisdiction specific. Approval in one country does not imply approval in another, and listing a product on this website does not imply that it is approved.
- South Africa
- [VERIFICATION REQUIRED]
- United States
- [VERIFICATION REQUIRED]
- European Union
- [VERIFICATION REQUIRED]
Documentation
Technical documentation available on request.
Product information on this website is provided for research and informational purposes only. Product status, permitted use and availability may vary by jurisdiction. Nothing on this website constitutes medical advice, diagnosis or treatment advice. Regulatory status and intended use should be independently verified before any product is considered for use.
Related Products
MOTS-c
10 mgSynthetic Peptide supplied as a 10 mg research presentation. Full technical information, research detail and documentation for this compound are pending verification.
SS-31
10 mgSynthetic Peptide supplied as a 10 mg research presentation. Full technical information, research detail and documentation for this compound are pending verification.
Have a technical or product enquiry?
Request specifications, documentation or availability information for this compound.